Actively Recruiting
Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems
Led by M.D. Anderson Cancer Center · Updated on 2026-05-04
100
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
M
M.D. Anderson Cancer Center
Lead Sponsor
S
Siemens Medical Solutions
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to compare two types of digital breast tomosynthesis (DBT) systems: narrow-angle and wide-angle. The study focuses on evaluating which system provides better visibility of masses and architectural distortions in breast imaging. It also gathers feedback from radiologists, technologists, and participants regarding the imaging experience and comfort. Participants will receive follow-up imaging using an FDA-approved DBT system that differs from their routine screening system. For example, if their standard screening used narrow-angle DBT, the study imaging will use wide-angle DBT, and vice versa. These images will be used for diagnosis and to guide further care. Throughout the study, participants will be monitored for safety and any adverse events for about one year. Researchers will also collect radiologist feedback, technologist experiences, and participant comfort survey responses. The study involves women undergoing standard screening mammography who can provide informed consent.
CONDITIONS
Brief Title
Comparison of Conspicuity of Masses and Architectural Distortions Between Wide- and Narrow-angle Digital Breast Tomosynthesis Systems
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women undergoing standard screening mammography.
- Ability to understand and sign consent.
You will not qualify if you...
- Pregnant women.
- Women unable to consent.
- Male patients.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single imaging session
Participants undergo standard follow-up imaging using a digital breast tomosynthesis system different from their routine screening to compare image quality.
1 visit (in-person)
Duration - Approximately 1 year
Participants are monitored for safety and adverse events related to the imaging procedure.
Trial Site Locations
Total: 1 location
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
B
Beatriz Adrada, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here